NSABP FOUNDATION, INC.
- Country
- đşđ¸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- NSABP Foundation Inc
- Registration Number
- NCT05178576
- Locations
- đşđ¸
UF Health Davis Cancer Pavilion and Shands Med Plaza, Gainesville, Florida, United States
đşđ¸University of Iowa, Iowa City, Iowa, United States
đşđ¸Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03628066
- Locations
- đşđ¸
Breast Cancer Care Specialist, Fountain Valley, California, United States
đşđ¸Orange Coast Blood and Cancer Care, Fountain Valley, California, United States
đşđ¸Saddleback Memorial Medical Center, Laguna Hills, California, United States
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Dietary Supplement: Folic AcidDietary Supplement: Vitamin B-12
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 33
- Registration Number
- NCT03626922
- Locations
- đşđ¸
UF Health Davis Cancer Pavilion & Shands Medical Plaza, Gainesville, Florida, United States
đşđ¸Cancer Care Specialists of Central Illinois, Decatur, Illinois, United States
đşđ¸Decatur Memorial Hospital, Decatur, Illinois, United States
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 35
- Registration Number
- NCT03457896
- Locations
- đşđ¸
Kaiser Permanente-Anaheim, Anaheim, California, United States
đşđ¸Kaiser Permanente-Baldwin, Baldwin Park, California, United States
đşđ¸Kaiser Permanente-Bellflower, Bellflower, California, United States
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
- Conditions
- HER2-negative Breast Cancer
- Interventions
- Diagnostic Test: Celcuity CELx HSF
- First Posted Date
- 2018-01-26
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 64
- Registration Number
- NCT03412643
- Locations
- đşđ¸
Arrowhead Regional Medical Center, Colton, California, United States
đşđ¸Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
đşđ¸University of Florida Cancer Center at Orlando Health, Orlando, Florida, United States
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
- Conditions
- Triple Negative Breast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 1550
- Registration Number
- NCT03281954
- Locations
- đşđ¸
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
đşđ¸Katmai Oncology Group, Anchorage, Alaska, United States
đşđ¸St. Bernard's Medical Center, Paragould, Arkansas, United States
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 45
- Registration Number
- NCT03102047
- Locations
- đşđ¸
Smilow Cancer Hospital Care Center at Guilford, Guilford, Connecticut, United States
đşđ¸Smilow Cancer Hospital Care Center at Yale, New Haven, Connecticut, United States
đşđ¸Yale University, Yale Cancer Center, New Haven, Connecticut, United States
Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 33
- Registration Number
- NCT03007407
- Locations
- đşđ¸
City of Hope, Duarte, California, United States
đşđ¸Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States
đşđ¸Smilow Cancer Hospital Care Center at North Haven, North Haven, Connecticut, United States
A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer
- Conditions
- Stage III (IIIB or IIIC) Colon Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-01-26
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 34
- Registration Number
- NCT02664077
- Locations
- đşđ¸
St. Joseph Hospital of Orange, Orange, California, United States
đşđ¸St. Joseph Heritage Healthcare, Santa Rosa, California, United States
đşđ¸Kaiser Permanente Medical Center - Vallejo, Vallejo, California, United States
A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
- Conditions
- Breast CancerBreast CarcinomaBreast Tumors
- Interventions
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 307
- Registration Number
- NCT02296801
- Locations
- đşđ¸
Long Beach Memorial Medical Center-Todd Cancer Institute, Long Beach, California, United States
đşđ¸University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
đşđ¸Cancer Care Specialists of Central Illinois, Decatur, Illinois, United States